Chemomab Therapeutics Ltd. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Chemomab Therapeutics Ltd. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q1 | 2023 | Mar 31, 2023 | ($8.75M) | May 11, 2023 |
| Q3 | 2022 | Sep 30, 2022 | ($8.08M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2022 | ($6.19M) | Aug 12, 2022 |
| Q3 | 2022 | Jun 30, 2022 | ($6.19M) | Nov 10, 2022 |
| Q2 | 2022 | Mar 31, 2022 | ($5.10M) | Aug 12, 2022 |
| Q1 | 2023 | Mar 31, 2022 | ($5.10M) | May 11, 2023 |
| Q3 | 2022 | Mar 31, 2022 | ($5.10M) | Nov 10, 2022 |
| Q3 | 2022 | Sep 30, 2021 | ($2.97M) | Nov 10, 2022 |
| Q3 | 2022 | Jun 30, 2021 | ($2.77M) | Nov 10, 2022 |
| Q2 | 2022 | Jun 30, 2021 | ($2.77M) | Aug 12, 2022 |
| Q3 | 2022 | Mar 31, 2021 | ($1.70M) | Nov 10, 2022 |
| Q2 | 2022 | Mar 31, 2021 | ($1.70M) | Aug 12, 2022 |
| Q1 | 2022 | Mar 31, 2021 | ($1.70M) | May 12, 2022 |
| Q3 | 2021 | Sep 30, 2020 | ($1.22M) | Nov 12, 2021 |
| Q2 | 2021 | Jun 30, 2020 | ($1.08M) | Aug 13, 2021 |
| Q3 | 2021 | Jun 30, 2020 | ($1.08M) | Nov 12, 2021 |
| Q2 | 2020 | Mar 31, 2020 | ($3.54M) | Aug 14, 2020 |
| Q3 | 2021 | Mar 31, 2020 | ($1.70M) | Nov 12, 2021 |
| Q1 | 2021 | Mar 31, 2020 | ($1.70M) | May 13, 2021 |
| Q3 | 2020 | Sep 30, 2019 | ($7.17M) | Nov 16, 2020 |